Keywords: New Zealand, PHARMAC, InterPharma, Bayer, Xarelto, Avelox, Copaxane

New Zealand’s PHARMAC enters deal with InterPharma for seven cancer drugs and with Bayer over Xarelto, Avelox and Copaxone

Article | 10 November 2010

Print This

New Zealand’s Pharmaceutical Management Agency (PHARMAC) has reached agreement with InterPharma Pty for seven oncology products and has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in